Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design.

Sechaud, Romain, Graf, Peter, Bigler, Hilde, Gruendl, E, Letzkus, Martin and Merz, Michael (2002) Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design. International journal of clinical pharmacology and therapeutics, 40 (1). pp. 35-40. ISSN 0946-1965

Abstract

Two formulations of valsartan (Diovan), 320 mg tablets and marketed 160 mg capsules, were evaluated for bioequivalence after single dosing.

Item Type: Article
Date Deposited: 28 Jan 2012 00:45
Last Modified: 01 Feb 2013 00:46
URI: https://oak.novartis.com/id/eprint/5609

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.